• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GLUCAGON-LIKE PEPTIDE 1

PPARgamma and drugs for Alzheimer’s and Diabetes

September 17, 2018Alzheimer's, Diabetes, Metabolic Disorders, Nervous System Disorders, Vizit Graphs
PPARgamma ad common drugs and two major diseases, Alzheimer’s and Diabetes

“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

CANCER CLOSTRIDIUM DIFFICILE RHEUMATOID ARTHRITIS IL17A SOD1 CANDIDA ALBICANS REMICADE TP53 CD4 INSULIN HELICOBACTER PYLORI ANGIOGENESIS ESCHERICHIA COLI TNF CELL DIVISION AUTOPHAGY IMMUNE RESPONSE PSEUDOMONAS AERUGINOSA BREAST CANCER METFORMIN PORPHYROMONAS GINGIVALIS TH17 CELLS DOXORUBICIN CASP3 IL23A CELL DEATH INFLAMMATION AGING CTLA4 ERBB-2 FOXP3 NEURODEGENERATIVE DISORDERS LISTERIA MONOCYTOGENES ALZHEIMER'S DISEASE STREPTOCOCCUS PNEUMONIAE STAPHYLOCOCCUS AUREUS DIABETES MELLITUS CELL PROLIFERATION IFNG PARKINSON DISEASE CELL DIFFERENTIATION IL6 APOPTOTIC PROCESS RECEPTOR 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

© 2020 Biovista Vizit All Rights Reserved.